Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Japanese Journal of Clinical Oncology|January 17, 2025
Cytokine release syndrome induced by dabrafenib and trametinib therapy in BRAF V600E-mutant non-small cell lung cancerToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.Thoracic Cancer|February 9, 2026
PD-L1 Expression and Histopathological Features in EGFR-Mutated Non-Small Cell Lung Cancer: Implications for Immune Checkpoint Inhibitors After EGFR-Tyrosine Kinase Inhibitors ResistanceToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.Respirology Case Reports|February 19, 2026
Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil KineticsToshiyuki Sumi, Taiki Ishigooka, Kazuya Takeda, et al.Lung Cancer (Amsterdam, Netherlands)|February 7, 2025
Dual onsets of small cell lung cancer with contrasting neuroendocrine features and immune microenvironments: A case reportToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.Respiratory Investigation|May 8, 2025
Switching to tezepelumab from other biologics in patients with severe asthma: a retrospective studyToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.Translational Lung Cancer Research|November 7, 2024
Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case reportToshiyuki Sumi, Takumi Ikeda, Kotomi Arioka, et al.Respiratory Investigation|September 5, 2024
Transesophageal ultrasound-guided bronchoscopic Acquire TBNB versus Vizishot2 TBNA needles for neoplastic lesions: A retrospective studyToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.JCO Oncology Practice|June 30, 2025
Prophylactic Interventions to Prevent Severe Skin Toxicities in Patients With Non-Small Cell Lung Cancer Treated With Nivolumab + Ipilimumab With or Without ChemotherapyToshiyuki Sumi, Kaori Kanamaru, Shunsuke Tsuji, et al.Pageof 1